Supply chains are helping distribute life-saving vaccines, but they’re also needed to help get the economy back to normal. We need to do both, but it won’t be easy.
As major pharma players—including Pfizer, J&J, Gilead, Moderna and AstraZeneca—announce vaccines for the COVID-19 virus that’s claimed over 1.3 million lives, life sciences companies have an increased focus on delivering their vaccines to millions—potentially billions—of people.
At the center of the COVID-19 storm, most healthcare providers generally did an exemplary job transitioning operations from on-premises to work-from-home. But that may have been the easy part.
Supply chain expert Ron Rod details how healthcare providers, payers and life sciences companies are responding to COVID-19 supply chain interruptions while preparing to emerge stronger in the future.